FDA — authorised 20 April 1977
- Application: ANDA085007
- Marketing authorisation holder: PVT FORM
- Local brand name: FEMOGEN
- Indication: TABLET — ORAL
- Status: approved
🇺🇸 ESTROGENS, ESTERIFIED in United States
FDA authorised ESTROGENS, ESTERIFIED on 20 April 1977
Marketing authorisations
FDA — authorised 20 April 1977
- Application: ANDA085008
- Marketing authorisation holder: PVT FORM
- Local brand name: FEMOGEN
- Indication: TABLET — ORAL
- Status: approved
FDA — authorised 28 September 1977
- Application: ANDA083376
- Marketing authorisation holder: ROCHE PALO
- Local brand name: EVEX
- Indication: TABLET — ORAL
- Status: approved
FDA — authorised 28 September 1977
- Application: ANDA084215
- Marketing authorisation holder: ROCHE PALO
- Local brand name: EVEX
- Indication: TABLET — ORAL
- Status: approved
FDA
- Application: ANDA086715
- Marketing authorisation holder: SOLVAY
- Local brand name: ESTRATAB
- Indication: TABLET — ORAL
- Status: approved
FDA
- Application: ANDA083209
- Marketing authorisation holder: SOLVAY
- Local brand name: ESTRATAB
- Indication: TABLET — ORAL
- Status: approved
FDA
- Application: ANDA085076
- Marketing authorisation holder: PVT FORM
- Local brand name: FEMOGEN
- Indication: TABLET — ORAL
- Status: approved
FDA
- Status: approved
ESTROGENS, ESTERIFIED in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Frequently asked questions
Is ESTROGENS, ESTERIFIED approved in United States?
Yes. FDA authorised it on 20 April 1977; FDA authorised it on 20 April 1977; FDA authorised it on 28 September 1977.
Who is the marketing authorisation holder for ESTROGENS, ESTERIFIED in United States?
PVT FORM holds the US marketing authorisation.